Oxford BioMedica Result of General Meeting and Directors Dealing
London, UK – 29 September 2016: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE: OXB), a leading gene and cell therapy group, announces, in accordance with Listing Rule 9.6.18, that…